Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 874 participants.
Also called NCT04217447
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 874 participants
- Sponsor
- Registry
-
NCT04217447
-
- Other papers using this trial's data
- Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Terminated
Technical summary
Registry record NCT04217447. Randomized; quadruple masking; primary purpose treatment. Start 2020-05-25 (actual); primary completion 2024-10-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
- Acronym
- AQUATIC
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- OAC + Aspirin 100mg od
- Intervention (Drug)
- OAC + placebo of Aspirin 100mg od
- Lead sponsor
- University Hospital, Brest
- Collaborator
- Bayer
Record details
- Record id
cardio:ct-nct04217447- Content hash
a260dfaaae0d9ad1a9a54c4aa7d54a731483229d6a032d6e1f7e49ce1db013a2